Crispr Therapeutics shares owned by EMC Capital Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by EMC Capital Management
from 13F filings
Historical chart of EMC Capital Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by EMC Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by EMC Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $45k | 700 | 64.29 |
| 2025-06-30 | $34k | 700 | 48.57 |
| 2025-03-31 | $51k | 1.5k | 34.00 |
| 2024-12-31 | $138k | 3.5k | 39.43 |
| 2024-09-30 | $216k | 3.3k | 64.86 |
| 2024-06-30 | $496k | 9.3k | 53.33 |
| 2024-03-31 | $66k | 1.0k | 66.00 |